The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Sterile Small Molecule Fill / Finish Services by Fill / Finish Technique (Aseptic Filling, Terminal Sterilization and Blow-fill-seal), Type of Packaging (Ampoule, Bottle, Pre-filled Syringe and Vial), Type of Dosage Form (Liquid, Lyophilized and Others) and Geography (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2020-2030

  • Lowest Price Guaranteed From USD 4,899

  • Published
    October 2020

  • Pages
    184

  • View Count
    471

Example Insights

Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Context Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Types-of-small-molecule-drug-products Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Distribution-by-scale-of-operations
Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Recent-Expansions Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Competitive-Analysis Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Global-Capacity-Analysis
Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Market-Forcast Sterile-Small-Molecule-Fill-Finish-Service-Providers-Market-Distribution-by-Type-of-Packaging  

 

Overview

Small molecule drugs account for nearly 90% of the contemporary therapeutics pipeline. In fact, in 2019, the FDA’s Center for Drug Evaluation and Research approved 48 small molecule drugs, representing 70% of the new molecular entities (NMEs) clearing regulatory review in the same year. Given that the demand for small molecule drugs is still on the rise, the importance of contract manufacturing and third party services is also increasing in the pharmaceutical industry. Sterile fill / finish is considered among the most crucial steps in the pharmaceutical production process. In fact, aseptic conditions during fill / finish operations are not only essential for ensuring end user safety, but also maintaining pharmacological efficacy and product quality. As small molecule APIs are gradually becoming more complex, the demand for appropriate aseptic fill / finish processes is growing.  

Given the high cost of specialized equipment and the affiliated expertise required for aseptic fill / finish operations, it is difficult for drug developer companies with limited finances and capacity constraints to meet clinical / commercial scale demands. This has led many of the smaller players in the industry and certain pharma giants, as well, to outsource various aspects of their production processes, including fill / finish, to contract service providers. Currently, over 130 companies are actively providing sterile fill / finish services for small molecules. In the recent past, many of the aforementioned service providers have also forged strategic alliances and / or acquired other players, in order to further enhance their respective service offerings. We believe that this trend is likely to persist in the foreseen future, as well. Overall, the contract services market for fill / finish of small molecule drugs is anticipated to witness steady growth, till 2030.

Scope of the Report

The ‘Sterile Small Molecule Fill / Finish Services Market, 2020-2030’ report features an extensive study of the current market landscape and the future potential of sterile fill / finish services for small molecule drugs. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: 

  • A detailed review of the overall landscape of contract fill / finish services market for small molecules, featuring a list of service providers and detailed analysis based on a number of relevant parameters, including developer information (year of establishment, company size and location of headquarters), scale of operation (preclinical, clinical and commercial), type of fill / finish technique (aseptic filling / terminal sterilization and blow-fill-seal), dosage forms handled (liquid, lyophilized, micelles / liposomes and powder), and types of primary packaging containers handled (vials / ampoules, pre-filled syringes / syringes / cartridges and bottles / others).
  • A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers, based on supplier strength (considering experience of the service provider) and portfolio  strength (considering the number of dosage forms handled, number of containers for which fill / finish service is being provided, number of fill / finish techniques adopted and scale of operation).  
  • Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific), which were shortlisted based on our proprietary company competitiveness analysis. Each profile provides an overview of the company, details related to their fill / finish service portfolio, financial performance (if available), and an informed future outlook. 
  • A detailed analysis of the expansions undertaken (since 2016) by various service providers, based on a number of parameters, including year of expansion, type of expansion (capacity expansion, capability expansion, new facility, geographical consolidation and geographical expansion), geographical location of facility and most active players (in terms of number of instances).
  • An estimate of the global, contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary research. The study examines the distribution of number of packaging units and volume of small molecules filled, across various types of packaging (ampoules, bottles, pre-filled syringes and vials), based on the size of the company / organization (small-sized, mid-sized and large / very large)  and geography (North America, Europe and Asia Pacific).
  • A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes; the study provides a list of equipment manufacturers providing robots suitable for pharmaceutical operations.
  • A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations; the study provides a list of suppliers providing the ready-to-use components.

One of the key objectives of the report was to estimate the existing market size and potential growth opportunities for sterile small molecule service providers. Based on parameters, such as such as growth of the overall pharmaceutical market, the cost associated with fill / finish operation and outsourcing trends related to these operations, we have provided an informed estimate on the likely evolution of the market over the period 2020-2030. Our year-wise projections of the current and future opportunity have further been segmented on the basis of 
[A] fill / finish technique (aseptic filling, terminal sterilization and blow-fill-seal)
[B] type of packaging (ampoules, bottles, pre-filled syringes and vials)
[C] type of dosage form (liquid, lyophilized and others) 
[D] key geographical regions (North America (US, Canada), Europe (UK, France, Germany, Italy, Spain and rest of the Europe), Asia-Pacific (Australia, India, South Korea and rest of the Asia), Middle East and North Africa and Latin America). 

To account for the uncertainties associated with this industry and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. The summary offers a high-level view on the likely evolution of the sterile small molecule service providers market in the mid to long term.

Chapter 3 provides a general introduction to pharmaceutical contract manufacturing industry. The chapter lays emphasis on the important sterile fill / finish techniques that are being adopted by the industry for packaging of small molecule drugs. It includes information on key factors that need to be considered during the selection of fill / finish service providers, as well as the advantages and associated risks or challenges related to outsourcing fill / finish operations.

Chapter 4 provides an overview of the overall sterile small molecule fill / finish contract services landscape. It includes information related to 130 contract service providers that are currently active in this domain. It features in-depth analyses of the market, based on a number of relevant parameters, such as year of establishment, company size and geographical location of the service providers, location of fill / finish facilities, information on various fill / finish techniques (aseptic filling, terminal sterilization and blow-fill-seal), types of dosage form (liquid, lyophilized, micelles / liposomes and powder / others), types of packaging (ampoules / vials, cartridges / pre-filled syringes / syringes and bottles / others) and scale of operation (preclinical, clinical and commercial).

Chapter 5 provides an insightful competitiveness analysis of the service providers that we came across during our research. The analysis compares the companies on the basis of supplier strength (based on the year of establishment of the service provider) and service portfolio strength (which takes into account the number of dosage forms handled, number of containers for which fill / finish service is being provided, number of fill / finish techniques adopted and scale of operation).

Chapter 6 features detailed profiles of some of the key players that are active in the sterile small molecule contract manufacturing domain. Each profile presents a brief overview of the company, its fill / finish service portfolio, financial information (if available), recent developments and an informed future outlook.

Chapter 7 presents detailed analyses of the expansions that have taken place since 2016. These have been analyzed on various parameters, including year of expansion, purpose of expansion (capacity expansion, capability expansion, new facility, geographical consolidation and geographical expansion), geographical location of the facility, and also highlights the most active players (in terms of number of instances) in the domain.

Chapter 8 features a comprehensive analysis of the global sterile small molecule fill / finish capacity, by taking into consideration the container processing capacities of various fill / finish service providers (as available on respective company websites). The study examines the distribution of global sterile small molecule fill / finish capacity of the industry in terms of number of packaging units, type of packaging (ampoules, bottles,  pre-filled syringes and vials), size of the manufacturer (small-sized, mid-sized and large / very large) and geography (North America, Europe and Asia-Pacific).

Chapter 9 presents a comprehensive market forecast analysis, highlighting the likely growth of sterile small molecules’ fill / finish services market till the year 2030. In order to provide a detailed future outlook, our projections have been segmented on the basis of fill / finish technique (aseptic filling, terminal sterilization and blow-fill-seal), type of packaging (ampoules, bottles, pre-filled syringes and vials), type of dosage form (liquid, lyophilized and other dosage form), and key geographical regions (North America (US, Canada), Europe (UK, France, Germany, Italy, Spain and rest of the Europe), Asia (Australia, India, South Korea and rest of the Asia), Middle East and North Africa and Latin America).

Chapter 10 is a case study focused on use of robotic systems in fill / finish operations. It provides a list of equipment used for fill / finish, highlighting the role of robotics in various manufacturing operations. It also includes list of companies providing robots for use in pharmaceutical production processes.

Chapter 11 is a case study which describes the use of ready-to-use packaging components in the aseptic fill / finish operations. It also provides a list of suppliers providing ready-to-use components.

Chapter 12 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario.

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Question Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Fill / Finish of Small Molecule Drugs
3.2.1. Aseptic Filling
3.2.2. Terminal Sterilization
3.2.3. Blow-Fill-Seal Technology

3.3. Guidelines for Selecting a Fill / Finish Service Provider
3.4. Risks and Challenges of Outsourcing Fill / Finish Operations
3.5. Advantages of Outsourcing Fill / Finish Operations

4. MARKET LANDSCAPE: STERILE SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS
4.1. Chapter Overview
4.2. Sterile Small Molecule Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size and Location of Headquarters
4.2.3. Analysis by Location of Fill / Finish Facilities
4.2.4. Analysis by Type of Fill / Finish Technique
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Type of Dosage Forms Filled
4.2.7. Analysis by Scale of Operation

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3 Assumptions and Key Parameters
5.3.1. Competitiveness Analysis: Aseptic Small Molecule Fill / Finish Service Providers in North America
5.3.2. Competitiveness Analysis: Aseptic Small Molecule Fill / Finish Service Providers in Europe
5.3.3. Competitiveness Analysis: Aseptic Small Molecule Fill / Finish Service Providers in Asia-Pacific

5.4. Contact Details of Key Service Providers

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Albany Molecular Research (AMRI)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Pii (Pharmaceutics International)
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. Ajinomoto Bio-Pharma Services
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Catalent Pharma Solutions
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Service Portfolio
6.5.4. Recent Developments and Future Outlook

6.6. Pfizer CentreOne
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Service Portfolio
6.6.4. Recent Developments and Future Outlook

6.7. Delpharm
6.7.1. Company Overview
6.7.2. Service Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Rompharm
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. CordenPharma
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Service Portfolio
6.9.4. Recent Developments and Future Outlook

6.10. Mithra CDMO
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Service Portfolio
6.10.4. Recent Developments and Future Outlook

6.11. Pierre Fabre
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Service Portfolio
6.11.4. Recent Developments and Future Outlook

6.12. APL
6.12.1. Company Overview
6.12.2. Service Portfolio
6.12.3. Recent Developments and Future Outlook

6.13. Square Pharmaceuticals
6.13.1. Company Overview
6.13.2. Financial Information
6.13.3. Service Portfolio
6.13.4. Recent Developments and Future Outlook

6.14. Wockhardt
6.14.1. Company Overview
6.14.2. Financial Information
6.14.3. Service Portfolio
6.14.4. Recent Developments and Future Outlook

7. RECENT EXPANSIONS
7.1. Chapter Overview
7.2. Sterile Small Molecule Fill / Finish Service Providers Market: Expansion Models
7.2.1. Analysis by Year of Expansion
7.2.2. Analysis by Purpose of Expansion
7.2.3. Analysis by Year of Expansion and Purpose of Expansion
7.2.4. Analysis by Company Size and Location of Headquarters
7.2.5. Analysis by Purpose of Expansion and Location of Facility
7.2.6. Most Active Players: Analysis by Number of Expansions
7.2.7. Analysis by Geographical Distribution

8. CAPACITY ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Global Installed Small Molecule Fill / Finish Capacity (by Number of Units)
8.3.1. Analysis by Type of Packaging
8.3.2. Analysis by Size of Manufacturer
8.3.3. Analysis by Location of Headquarters

8.4. Global Installed Small Molecule Fill / Finish Capacity (by Volume)
8.4.1. Analysis by Type of Packaging
8.4.2. Analysis by Size of Manufacturer
8.4.3. Analysis by Location of Headquarters

9. MARKET SIZING AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Forecast Methodology
9.3. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030
9.3.1. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Fill / Finish Technique
9.3.2. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Packaging
9.3.3. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Dosage Form
9.3.4. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Geographical Region
9.3.4.1 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Countries
9.3.4.2. Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.3. Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Packaging
9.3.4.4. Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Dosage Form
9.3.4.5. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Countries
9.3.4.6. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.7. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Packaging
9.3.4.8. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Dosage Form
9.3.4.9. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Countries
9.3.4.10. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.11. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Type of Packaging
9.3.4.12. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Type of Dosage Form
9.3.4.13. Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Countries
9.3.4.14. Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.15. Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Packaging
9.3.4.16. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Countries
9.3.4.17. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.18. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Packaging
9.3.4.19. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Dosage Form

10. CASE STUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
10.1. Chapter Overview
10.2. Contract Service Providers: List of Fill / Finish Equipment
10.3. Role of Robotic Systems in Fill / Finish Operations
10.3.1. Types of Robots Used in Pharmaceutical Operations
10.3.2. Key Considerations for Selecting a Robotic System
10.3.3. Advantages of Robotic Systems
10.3.4. Disadvantages of Robotic Systems

10.4. Companies Providing Robots for Use in the Pharmaceutical Industry
10.5. Concluding Remarks

11. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS
11.1. Chapter Overview
11.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
11.2.1. Advantages of Ready-to-Use Packaging Components
11.2.2. Disadvantages of Ready-to-Use Packaging Components

11.3. Companies Providing Ready-to-Use Packaging Components
11.4. Concluding Remarks

12. CONCLUDING REMARKS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Fill / Finish Process Map
Figure 3.2 Blow Fill Seal Process
Figure 3.3 Key Considerations for Selecting a CMO Partner
Figure 3.4 Risks and Challenges of Outsourcing Fill / Finish Operations
Figure 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
Figure 4.3 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 4.4 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Fill / Finish Technique
Figure 4.5 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Packaging
Figure 4.6 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Dosage Forms Filled
Figure 4.7 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 5.1 Competitiveness Analysis: Sterile Small Molecule Fill / Finish Service Providers in North America
Figure 5.2 Competitiveness Analysis: Sterile Small Molecule Fill / Finish Service Providers in Europe
Figure 5.3 Competitiveness Analysis: Sterile Small Molecule Fill / Finish Service Providers in Asia-Pacific
Figure 6.1 Catalent Pharma Solutions: Annual Revenues, 2016-2019 (USD Million)
Figure 6.2 Pfizer CentreOne: Annual Revenues, 2016-2019 (USD Million)
Figure 6.3 CordenPharma: Annual Revenues, 2018-2019 (EUR Million)
Figure 6.4 Mithra CDMO: Annual Revenues, 2016-2019 (EUR Million)
Figure 6.5 Pierre Fabre: Annual Revenues, 2016-2019 (EUR Billion)
Figure 6.6 Square Pharmaceuticals: Annual Revenues, 2016-2019 (BDT Billion)
Figure 6.7 Wockhardt: Annual Revenues, 2016-2019 (USD Million)
Figure 7.1 Recent Expansions: Cumulative Year-Wise Trend, 2016-2020 (Till June)
Figure 7.2 Recent Expansions: Distribution by Purpose of Expansion
Figure 7.3 Recent Expansion: Distribution by Purpose of Expansion and Year of Expansion (2016-2020)
Figure 7.4 Recent Expansions: Distribution by Location of Headquarters and Company Size
Figure 7.5 Recent Expansions: Distribution by Location of Facility and Purpose of Expansion
Figure 7.6 Most Active Players: Distribution by Number of Recent Expansions
Figure 7.7 Recent Expansions: Distribution by Geography and Year, 2016-2020
Figure 8.1 Global Installed Small Molecule Fill / Finish Capacity (by Number of Units)
Figure 8.2 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Number of Units)
Figure 8.3 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Number of Units)
Figure 8.4 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Number of Units)
Figure 8.5 Global Installed Small Molecule Fill / Finish Capacity (by Volume)
Figure 8.6 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Volume)
Figure 8.7 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Volume)
Figure 8.8 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Volume)
Figure 9.1 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030 (USD Million)
Figure 9.2 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.3 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.4 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.5 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Geographical Region (USD Million)
Figure 9.6 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Countries (USD Million)
Figure 9.7 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.8 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.9 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.10 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Countries (USD Million)
Figure 9.11 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.12 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.13 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Dosage Form, 2020-2030 (USD Million)
Figure 9.14 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Countries (USD Million)
Figure 9.15 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.16 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.17 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.18 Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.19 Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.20 Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.21 Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.22 Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.23 Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 10.1 Key Considerations for Selecting a Robotic System
Figure 10.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 11.1 Drivers of Ready-to-Use Platform

List Of Tables

Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: List of Companies
Table 4.1 Key Service Providers’ Contact Details
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: List of Companies Profiled
Table 4.1 Albany Molecular Research (AMRI): Recent Developments and Future Outlook
Table 4.1 Pii (Pharmaceutics International): Recent Developments and Future Outlook
Table 4.1 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
Table 4.1 Catalent Pharma Solutions: Recent Developments and Future Outlook
Table 4.1 Pfizer CentreOne: Recent Developments and Future Outlook
Table 4.1 Delpharm: Recent Developments and Future Outlook
Table 4.1 Rompharm: Recent Developments and Future Outlook
Table 4.1 CordenPharma: Recent Developments and Future Outlook
Table 4.1 Mithra CDMO: Recent Developments and Future Outlook
Table 4.1 Pierre Fabre: Recent Developments and Future Outlook
Table 4.1 APL: Recent Developments and Future Outlook
Table 4.1 Square Pharmaceuticals: Recent Developments and Future Outlook
Table 4.1 Wockhardt: Recent Developments and Future Outlook
Table 4.1 Sterile Small Molecule Fill / Finish Services: List of Recent Expansions
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Information on Equipment Used
Table 4.1 List of Pharmaceutical Robotics Manufacturers
Table 4.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Year of Establishment
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Fill / Finish Technique
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Packaging
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Dosage Forms Filled
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Scale of Operation
Table 4.1 Catalent Pharma Solutions: Annual Revenues, 2016-2019 (USD Million)
Table 4.1 Pfizer CentreOne: Annual Revenues, 2016-2019 (USD Million)
Table 4.1 CordenPharma: Annual Revenues, 2018-2019 (EUR Million)
Table 4.1 Mithra CDMO: Annual Revenues, 2016-2019 (EUR Million)
Table 4.1 Pierre Fabre: Annual Revenues, 2016-2019 (EUR Billion)
Table 4.1 Square Pharmaceuticals: Annual Revenues, 2016-2019 (BDT Billion)
Table 4.1 Wockhardt: Annual Revenues, 2016-2019 (USD Million)
Table 4.1 Recent Expansions: Cumulative Year-Wise Trend, 2016-2020 (Till June)
Table 4.1 Recent Expansions: Distribution by Purpose of Expansion
Table 4.1 Recent Expansion: Distribution by Purpose of Expansion and Year of Expansion (2016-2020)
Table 4.1 Recent Expansions: Distribution by Location of Headquarters and Company Size
Table 4.1 Recent Expansions: Distribution by Location of Facility and Purpose of Expansion
Table 4.1 Most Active Players: Distribution by Number of Recent Expansions
Table 4.1 Recent Expansions: Distribution by Geography and Year, 2016-2020
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity (by Volume)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Volume)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Volume)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Volume)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030 (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Geographical Region (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Countries (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Countries (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Countries (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)

List Of Company

  1. ABB
  2. AbbVie Contract Manufacturing
  3. Aenova
  4. Afton Scientific
  5. Ajinomoto Bio-Pharma
  6. Akorn
  7. Alanza
  8. Alcami
  9. Alkermes Contract Pharma Services
  10. Allergy Laboratories
  11. AMRI
  12. Amsino International
  13. APG Europe
  14. APL
  15. Aptar Pharma
  16. ARaymond Life
  17. Argonaut
  18. Asept Pak
  19. Aseptic Technologies 
  20. Avara Pharmaceutical Services
  21. Axcellerate Pharma
  22. Baccinex
  23. Basic Pharma
  24. Bausch & Ströbel
  25. BAUSCH Advanced Technology 
  26. Baxter International
  27. BD
  28. BePharBel Manufacturing
  29. Berkshire Sterile Manufacturing
  30. bioserv
  31. BioTechnique
  32. BirgiMefar
  33. Bosch Packaging Technology
  34. Bryllan
  35. BSP Pharmaceuticals
  36. Burrard Pharmaceuticals
  37. Capmatic
  38. CARBOGEN AMCIS
  39. Catalent Pharma Solutions
  40. Celonic
  41. Cenexi
  42. Chase Longman
  43. Chemigran 
  44. Ciron Drugs & Pharmaceuticals
  45. Cobra Biologics
  46. COC Farmaceutici 
  47. Concord Drugs
  48. Corden Pharma
  49. Cozzoli Machine Company
  50. Creosalus
  51. Curida
  52. Daikyo Seiko
  53. Dalton Pharma Services
  54. Datwyler Sealing Solutions (Datwyler Group)
  55. Delpharm 
  56. DENSO 
  57. Dhruv Life Sciences
  58. Disposable Lab
  59. DWK Life Sciences
  60. EirGen Pharma
  61. EMA Pharmaceuticals
  62. EMCM
  63. Emergent BioSolutions
  64. Eurofins
  65. Euro-Med Laboratories
  66. EVER Pharma
  67. Evonik Health Care
  68. Exelead
  69. FANUC America
  70. FAREVA
  71. Flamingo Pharmaceuticals
  72. Fresenius Kabi Contract Manufacturing 
  73. Gebro Pharma
  74. Gerresheimer
  75. Gland Pharma
  76. GP Pharm
  77. Grand River Aseptic Manufacturing
  78. Groninger
  79. Gröninger / SPC
  80. GSK
  81. Hanford Pharmaceuticals
  82. Healthy Life Pharma
  83. Hisun Pharmaceuticals USA
  84. Horizon Pharmaceuticals
  85. iBio
  86. IDT Australia
  87. IMA
  88. Indicia
  89. Industria Macchine Automatiche (IMA)
  90. Injectalia
  91. Jubilant HollisterStier
  92. Kawasaki Heavy Industries
  93. KP Pharmaceutical Technology
  94. KUKA
  95. Legacy Pharmaceuticals
  96. LESVI
  97. Lifecore Biomedical
  98. Lohmann Pharma Herstellung
  99. Lomapharm
  100. Lonza
  101. LSNE Contract Manufacturing
  102. Lubrizol Life Science
  103. Lyophilization Technology
  104. M&O Perry
  105. Magle Chemoswed
  106. Makcur Laboratories
  107. Marchesini Group
  108. Massman Automation Designs
  109. Mithra CDMO
  110. Mitsubishi Electric
  111. Navesta
  112. Nephron Pharmaceuticals
  113. NextPharma
  114. Ningbo Zhengli Pharmaceutical Packing
  115. Nipro PharmaPackaging
  116. Nova Laboratories
  117. Novex Innovations
  118. Novocol Pharma
  119. Oakwood Labs
  120. Ompi (Stevanato Group)
  121. OMRON Industrial Automation
  122. OPTIMA pharma
  123. Orion Corporation
  124. PaizaBio
  125. Pall Life Sciences
  126. PANPHARMA
  127. Patheon (Thermo Fisher Scientific)
  128. Pfizer CentreOne
  129. Pharma Stulln
  130. Pharma-Q
  131. PHARMASTER laboratories
  132. Pierre Fabre
  133. Pii (Pharmaceutics International Inc.)
  134. Piramal Pharma Solutions
  135. Pisa Farmaceutica
  136. Plastikon Healthcare
  137. PMI BioPharma Solutions
  138. Polfa Tarchomin
  139. PrimaPharma
  140. Prince Sterilization Services
  141. PYRAMID Laboratories
  142. Recipharm
  143. Renaissance Lakewood
  144. ROMMELAG CMO
  145. Rompharm
  146. ROTA Verpackungstechnik
  147. ROVI
  148. Salvat
  149. Samsung Biologics
  150. SCHOTT 
  151. Seiko Epson
  152. Selkirk Pharma
  153. Sentiss Pharma
  154. Siegfried
  155. Singota Solutions
  156. SiO2 Medical Products
  157. Square Pharmaceuticals
  158. Staubli
  159. Swissfillon
  160. Symbiosis Pharmaceutical Services
  161. Sypharma
  162. Tekpak
  163. Therapure Biomanufacturing
  164. Transcoject
  165. TriPharm Services (Alcami)
  166. Unicep
  167. Unipharma
  168. Unither Pharmaceuticals
  169. Universal Robots
  170. University of Iowa Pharmaceuticals
  171. Unolab Manufacturing
  172. Vanrx Pharmasystems
  173. Vetter Pharma
  174. V-nano
  175. VxP Pharma
  176. Watson-Marlow
  177. West Pharmaceutical Services
  178. Wockhardt
  179. Wuxi Griffin Pharmaceuticals
  180. Yaskawa Electric
  181. Zoetis

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 4,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com